Conavi Medical Corp.
CNVI.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -24.44% | -84.48% | -90.75% | 560.43% | -75.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.44% | -84.48% | -90.75% | 560.43% | -75.89% |
| Cost of Revenue | -92.64% | -99.79% | -113.33% | 17.92% | -25.18% |
| Gross Profit | 818.56% | 205.66% | 667.42% | 9,257.97% | -97.43% |
| SG&A Expenses | -10.69% | -44.36% | -6.49% | 5.18% | 4.49% |
| Depreciation & Amortization | -17.50% | -9.56% | -24.43% | -24.11% | -24.82% |
| Other Operating Expenses | -83.52% | -- | -- | 18.77% | -58.39% |
| Total Operating Expenses | -19.45% | -50.09% | -22.24% | 8.45% | -14.57% |
| Operating Income | 19.07% | 48.54% | 15.53% | 55.07% | -6.34% |
| Income Before Tax | 58.17% | 72.97% | 58.71% | 31.90% | -124.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 58.17% | 72.97% | 58.71% | 31.90% | -124.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.17% | 72.97% | 58.71% | 31.90% | -124.18% |
| EBIT | 19.07% | 48.54% | 15.53% | 55.07% | -6.34% |
| EBITDA | 19.94% | 48.98% | 14.63% | 55.64% | -7.42% |
| EPS Basic | 96.66% | 97.57% | 94.25% | 90.05% | -123.82% |
| Normalized Basic EPS | 95.77% | 95.93% | 89.25% | 84.04% | -28.46% |
| EPS Diluted | 96.66% | 97.57% | 94.25% | 90.05% | -123.82% |
| Normalized Diluted EPS | 95.77% | 95.93% | 89.25% | 84.04% | -28.46% |
| Average Basic Shares Outstanding | 1,151.98% | 1,012.79% | 618.64% | 584.65% | 0.15% |
| Average Diluted Shares Outstanding | 1,151.98% | 1,012.79% | 618.64% | 584.65% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |